- Home
- XBIT vs ELA Comparison
XBIT vs ELA Comparison
Compare XBIT & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- ELA
- Stock Information
- Founded
- XBIT 2005
- ELA 1965
- Country
- XBIT United States
- ELA United States
- Employees
- XBIT N/A
- ELA N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- ELA Consumer Specialties
- Sector
- XBIT Health Care
- ELA Consumer Discretionary
- Exchange
- XBIT Nasdaq
- ELA Nasdaq
- Market Cap
- XBIT 194.5M
- ELA 173.1M
- IPO Year
- XBIT 2015
- ELA N/A
- Fundamental
- Price
- XBIT $3.25
- ELA $6.73
- Analyst Decision
- XBIT
- ELA Strong Buy
- Analyst Count
- XBIT 0
- ELA 1
- Target Price
- XBIT N/A
- ELA $7.00
- AVG Volume (30 Days)
- XBIT 52.0K
- ELA 17.3K
- Earning Date
- XBIT 03-14-2025
- ELA 03-19-2025
- Dividend Yield
- XBIT N/A
- ELA N/A
- EPS Growth
- XBIT N/A
- ELA N/A
- EPS
- XBIT N/A
- ELA 0.25
- Revenue
- XBIT N/A
- ELA $165,946,534.00
- Revenue This Year
- XBIT N/A
- ELA $1.61
- Revenue Next Year
- XBIT N/A
- ELA $6.30
- P/E Ratio
- XBIT N/A
- ELA $27.13
- Revenue Growth
- XBIT N/A
- ELA N/A
- 52 Week Low
- XBIT $3.25
- ELA $4.20
- 52 Week High
- XBIT $9.96
- ELA $7.88
- Technical
- Relative Strength Index (RSI)
- XBIT 26.88
- ELA 39.08
- Support Level
- XBIT $3.40
- ELA $6.62
- Resistance Level
- XBIT $3.69
- ELA $7.05
- Average True Range (ATR)
- XBIT 0.20
- ELA 0.35
- MACD
- XBIT 0.05
- ELA -0.06
- Stochastic Oscillator
- XBIT 3.85
- ELA 42.47
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About ELA Envela Corporation
Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.